The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Building viral vector capacity and capabilities to realise the promise of gene therapies
Webinar On Demand
Speaker:
Chris Murphy, VP & General Manager, Viral Vector Services
Peter Shapiro, Senior Director, GlobalData
Abstract:
-Challenges and opportunities of bringing viral vector products to market
-Importance of building capacity and capabilities to realize the promise of gene therapies
-Addressing scalability challenges